化合物CCT137690 T2611
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
2 mg | 1095382-05-0 | ¥383.00 | 询底价 |
50 mg | 1095382-05-0 | 面议 | 询底价 |
25 mg | 1095382-05-0 | ¥1,720.00 | 询底价 |
1 mg | 1095382-05-0 | ¥273.00 | 询底价 |
1 mL | 1095382-05-0 | ¥793.00 | 询底价 |
10 mg | 1095382-05-0 | ¥892.00 | 询底价 |
5 mg | 1095382-05-0 | ¥653.00 | 询底价 |
Product Introduction
Bioactivity
英文名: CCT 137690
描述: CCT 137690是一种有口服活性的极光激酶抑制剂,对极光激酶A、B 和C 的IC50值分别为15、25 和19 nM。
细胞实验: The effects of CCT137690 on cell proliferation are analyzed with the colorimetric 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Cells such as SW620 and A2780 are plated in 96-well plates at 2.5 × 103 per well and are treated with a range of 0 to 50 μM of CCT137690 for 72 hours. The absorbance is measured at 570 nm using the Wallac VICTOR2TM 1420 Multilabel Counter.(Only for Reference)
激酶实验: Flashplate assay for identification and evaluation of Aurora inhibitors: On this assay 384-well Basic Flashplate? as solid assay platform is used. The plates are coated overnight at 4 °C with dithiothreitol (DTT) at 100 μg/mL in PBS buffer and used after being washed twice with PBS. 5 μL of CCT137690 in 2% DMSO is added to each well followed by 15 μL master mix of kinase buffer (50 mM Tris pH 7.5, 10 mM NaCl, 2.5 mM MgCl2, 1 mM myelin basic protein (MBP), 20 μM ATP, and 0.025 μCi/μL 33P-ATP). Finally, 250 ng per well of Aurora-A enzyme is added. The plate is shaken for approximately 2 min on a flat-bed plate shaker and incubated for 2 hours at room temperature. The reaction is stopped by washing the plate twice on a 16-pin wash with 10 mM sodium pyrophosphate. The plate is then read on a TopCount-NXTTM. For the determination of the inhibitory activity against Aurora-B or Aurora-C, the same conditions are followed in the assay using Aurora-B or Aurora-C enzymes.
体外活性: 在转基因鼠成神经细胞瘤模型中,CCT137690明显抑制肿瘤细胞生长.在SW620结肠癌移植瘤模型中, 口服CCT137690能够抑制细胞生长.
体内活性: 对于hERG离子通道(IC50=3.0 μM),CCT137690能够起到抑制作用。在多种人类不同器官肿瘤细胞系中, CCT137690能够有效抑制细胞生长。对于SW620结肠癌细(GI50=0.3 μM),A2780卵巢癌细胞(GI50=0.14 μM)。
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 55.2 mg/mL (100 mM)
关键字: CCT-137690 | CCT 137690 | Inhibitor | inhibit | Aurora Kinase | Apoptosis
相关产品: Ezatiostat | Griseofulvin | Clofarabine | Scoulerine | Cyclovirobuxine D | GSK1059615 | Antitumor agent-96 | Capecitabine | Calcium dobesilate | Mitotane
相关库: Anti-Aging Compound Library | Cell Cycle Compound Library | Anti-Cancer Compound Library | Inhibitor Library | Kinase Inhibitor Library | Epigenetics Compound Library | Highly Selective Inhibitor Library | Autophagy Compound Library | NO PAINS Compound Library | Bioactive Compound Library
化合物CCT137690 T2611信息由TargetMol中国为您提供,如您想了解更多关于化合物CCT137690 T2611报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途